000 01483 a2200385 4500
005 20250511180730.0
264 0 _c19930427
008 199304s 0 0 eng d
040 _aNLM
_beng
_cNLM
100 1 _aPotter van Loon, B J
245 0 0 _aFluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.
_h[electronic resource]
260 _bInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
_cDec 1992
300 _aS55-61 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aDiabetes Mellitus
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFluoxetine
_xpharmacology
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlucose Clamp Technique
650 0 4 _aHumans
650 0 4 _aInsulin
_xpharmacology
650 0 4 _aInsulin Resistance
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aObesity
700 1 _aRadder, J K
700 1 _aFrölich, M
700 1 _aKrans, H M
700 1 _aZwinderman, A H
700 1 _aMeinders, A E
773 0 _tInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
_gvol. 16 Suppl 4
_gp. S55-61
999 _c1344911
_d1344911